Haleon plc (FRA:H6D0)

Market Cap	37.36B
Revenue (ttm)	12.85B
Net Income (ttm)	1.78B
Shares Out	n/a
EPS (ttm)	0.19
PE Ratio	21.04
Forward PE	n/a
Dividend	0.08 (1.84%)
Ex-Dividend Date	Apr 24, 2025

Volume	251
Average Volume	730
Open	4.166
Previous Close	4.173
Day's Range	4.166 - 4.200
52-Week Range	4.048 - 5.112
Beta	n/a
RSI	39.55
Earnings Date	Jul 31, 2025

About Chimerix

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprisi...

• Industry: Pharmaceutical Preparations
• Founded: 1715
• Employees: 24,561
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: H6D0

Financial Performance

In 2024, Haleon's revenue was 11.23 billion, a decrease of -0.61% compared to the previous year's 11.30 billion. Earnings were 1.44 billion, an increase of 37.46%.